Please login to the form below

Not currently logged in
Email:
Password:

Hall & Partners launch new consultancy OpenMind

Picks Jen Drexler to lead its new offering

Jen Drexler

Global strategic brand consultancy Hall & Partners has launched OpenMind, a specialist consultancy offering collaborative approach on brand and innovation solutions.

It will be run by managing partner Jen Drexler - who has spent the past 20 years working with clients such as Pfizer, Johnson & Johnson, Ikea, Bloomingdales and Estee Lauder, and will aim to tackle the “ever-increasing pressure on brands for growth”.

She said: “In our post-truth era, brands must be honest with themselves, and brave enough to challenge their own status quo.

“I always admired Hall & Partners’ global reach, deep client relationships and cutting-edge approaches for translating human truths for the world’s biggest brands.

“I look forward to working with clients to co-create and craft their blueprints for the future.”

Drexler was previously executive vice president for research and strategy agency Now What and held roles at Ketchum Communications and Insight Strategy Group.

Vanella Jackson, CEO of Hall & Partners, said: “In a dynamic, changing environment, identifying opportunities for growth is challenging.

“Rapid innovation experimentation is vital to ensure brands survive and prosper.

“Jen brings with her a wealh of knowledge and a history of non-traditional approaches to insights and innovation that clients love.”

Article by
Gemma Jones

30th June 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics